| amyloid light chain protein |
a pathological fibrillar low-molecular-weight protein occurring in immunocyte-derived amyloidosis; it is structurally and immunologically similar to the variable region of either the kappa chains or the lambda chains of immunoglobulins. Called also AL p. See also amyloid (def. 3).
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
|---|---|
| amyloid polyneuropathy |
polyneuropathy caused by amyloidosis; symptoms may include dysfunction of the autonomic nervous system, carpal tunnel syndrome, and sensory disturbances in the extremities such as numbness, hyperesthesia, or paresthesia. See also familial amyloid p.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
| amyl nitrite |
The chemical compound amyl nitrite (or isoamyl nitrite) is an Alkyl nitrite.It has a characteristic penetrating odour, and produces marked effects on the human body when its vapour is inhaled. It acts as a vasodilator (expanding blood vessels and thus lowering blood pressure) and finds applications in medicine in the treatment of heart disease such as angina. Amyl nitrite is also used to treat cyanide poisoning. ...
Ãâó: en.wikipedia.org/wiki/Amyl_nitrite
|
| amyloidosis |
A group of diseases in which protein is deposited in specific organs (localized amyloidosis) or throughout the body (systemic amyloidosis). Amyloidosis may be either primary (with no known cause) or secondary (caused by another disease, including some types of cancer). Generally, primary amyloidosis affects the nerves, skin, tongue, joints, heart, and liver; secondary amyloidosis often affects the spleen, kidneys, liver, and adrenal glands.
Ãâó: www.stjude.org/glossary
|
| amylin |
A peptide consisting of 37 amino-acid residues that is secreted with insulin and might act to modulate its stimulatory effects on glucose metabolism in muscle. Also known as islet amyloid peptide.
Ãâó: www.nature.com/nrn/journal/v2/n4/glossary/nrn0401_...
|